Iptacopan hydrochloride monohydrate is the monohydrate form of iptacopan hydrochloride. It is a complement factor B inhibitor approved for the treatment of adults with paroxysmal nocturnal hemoglobinuria. Among its listed roles, it functions as a complement factor B inhibitor and an immunomodulator. It includes a iptacopan hydrochloride. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Iptacopan hydrochloride monohydrate and LNP023 hydrochloride monohydrate. Its PubChem CID is 156613702.
Iptacopan hydrochloride
| CAS No | 2447007-60-3 |
|---|---|
| Molecular Formula | C25H33ClN2O5 |
| Molecular Weight | 477.0 g/mol |
| Synonyms | 4-[(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl]benzoic acid;hydrate;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Iptacopan hydrochloride monohydrate is the monohydrate form of iptacopan hydrochloride. It is a complement factor B inhibitor approved for the treatment of adults with paroxysmal nocturnal hemoglobinuria.
The listed CAS number is 2447007-60-3.
The listed molecular formula is C25H33ClN2O5.
The listed molecular weight is 477.0 g/mol.
4-[(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl]benzoic acid;hydrate;hydrochloride.
The source lists Iptacopan hydrochloride monohydrate and LNP023 hydrochloride monohydrate.